Minocycline topical - Pfizer/Sunstar
Alternative Names: Dentomycin; LS 007; Minomycin; PerioclineLatest Information Update: 05 Nov 2023
Price :
$50 *
At a glance
- Originator Sunstar; Wyeth K.K.
- Developer Sunstar
- Class Amides; Anti-inflammatories; Antiacnes; Antibacterials; Dimethylamines; Eye disorder therapies; Neuroprotectants; Skin disorder therapies; Small molecules; Tetracyclines
- Mechanism of Action Protein 30S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Periodontitis
- No development reported Anthrax; Peri-implantitis
Most Recent Events
- 28 Jan 2020 No recent reports of development identified for clinical-Phase-Unknown development in Peri-implantitis in South Korea (Topical, Gel)
- 16 Oct 2009 Wyeth has been acquired by Pfizer
- 31 Dec 2003 Wyeth-Lederle Japan is now called Wyeth K.K.